Crizotinib Capsules 250mg
Introduction
Access to quality-assured oncology medicines is an important consideration for hospitals, pharmaceutical importers, healthcare distributors, and institutional procurement organisations. When sourcing targeted anticancer medicines internationally, buyers need to evaluate product specifications, manufacturer credentials, quality documentation, regulatory requirements, and shipping arrangements before confirming an order.
India has an established pharmaceutical manufacturing and export industry, supplying finished medicines to international markets. For eligible pharmaceutical buyers, Indian suppliers may provide additional sourcing options, subject to product availability, manufacturer requirements, and destination-country regulations.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, offers pharmaceutical products across multiple therapeutic categories. International buyers looking for crizotinib capsules 250 mg can contact the company to enquire about potential sourcing options. The exact product, manufacturer, current availability, supporting documentation, and export eligibility should be confirmed before placing an order.
This guide explains how to evaluate a crizotinib supplier from India, verify product quality, review pharmaceutical export documentation, and plan a responsible international procurement process.
Key Highlights
- Generic name: Crizotinib.
- Strength: 250 mg per capsule.
- Dosage form: Oral hard capsule for the referenced presentation.
- Therapeutic category: Targeted anticancer medicine; kinase inhibitor.
- Uses: Certain cancers with specific molecular characteristics, according to the applicable approved product information.
- Potential buyers: Authorised pharmaceutical importers, wholesalers, distributors, hospital procurement teams, and eligible institutional buyers.
- Important checks: Manufacturer identity, product specifications, batch documentation, shelf life, storage conditions, and regulatory approval.
- Supplier enquiry: Contact Dolphin Pharmaceuticals to confirm whether the required product can be sourced for the intended market.
Product availability and approved indications must be verified for the specific medicine and destination country.
Understanding Crizotinib Capsules 250 mg
Crizotinib is an oral targeted anticancer medicine that inhibits certain tyrosine kinases, including anaplastic lymphoma kinase (ALK) and ROS1. These molecular targets are relevant to particular cancers in which specific genetic abnormalities are present.
Crizotinib is used for certain forms of advanced or metastatic non-small cell lung cancer (NSCLC) with relevant molecular characteristics. Depending on the product's approved label and jurisdiction, it may also be indicated for selected paediatric conditions, including particular forms of ALK-positive anaplastic large cell lymphoma and inflammatory myofibroblastic tumour.
The appropriate indication depends on the exact product approval and the patient's clinical circumstances. Testing for the relevant molecular alteration is required when specified by the approved prescribing information.
For pharmaceutical procurement teams, these distinctions are important. A medicine described broadly as an anticancer product should not automatically be considered appropriate for every cancer type.
Crizotinib is a prescription medicine, and treatment decisions must be made by qualified oncology professionals.
Crizotinib Capsules 250 mg: Product Details
Buyers should establish the exact product specifications before requesting a quotation or approving a purchase.
- Generic name: Crizotinib.
- Strength: 250 mg per capsule.
- Dosage form: Oral hard capsule.
- Therapeutic category: Targeted anticancer medicine; kinase inhibitor.
- Approved uses: Depend on the specific product label and destination market.
- Route of administration: Oral.
- Manufacturer: Confirm the actual manufacturer and manufacturing site.
- Brand name: Specify a preferred brand, if applicable.
- Packaging: Confirm the available pack size and packaging configuration.
- Storage: Follow the approved product label. Some crizotinib capsule presentations specify storage below 30°C.
- Shelf life: Verify the batch expiry date and remaining shelf life.
- Availability: Confirm directly with the supplier.
- Export eligibility: Subject to applicable export, registration, and import requirements.
These details describe the general product requirement and do not confirm that Dolphin Pharmaceuticals currently stocks a particular brand or batch.
Why Consider a Crizotinib Supplier from India?
International pharmaceutical buyers may evaluate Indian suppliers as part of their sourcing strategy. However, supplier selection should be based on verifiable product information, appropriate documentation, regulatory compliance, and clear commercial terms.
1. Pharmaceutical Sourcing Options
Indian pharmaceutical suppliers operate across multiple therapeutic categories. Depending on their portfolios and supply arrangements, they may be able to review enquiries for specific finished medicines.
To help assess a crizotinib sourcing request, buyers should provide:
- Required strength and dosage form.
- Preferred brand or manufacturer, if applicable.
- Required quantity and packaging.
- Destination country.
- Known registration and import requirements.
- Required quality and regulatory documentation.
Clear specifications help reduce product mismatches and support more accurate quotations.
2. Manufacturer Transparency
The exporter and actual manufacturer may be different organisations. Buyers should establish whether the supplier manufactures the medicine directly or sources it from another pharmaceutical company.
Verify the manufacturer's legal name, manufacturing site where relevant, product label, and supporting documents before approving an order.
3. Quality Documentation
Quality assurance is an essential part of oncology medicine procurement. Buyers should request documentation applicable to the exact product and transaction.
Depending on the requirements, documents may include product specifications, batch information, a Certificate of Analysis, manufacturing details, and relevant quality certificates.
The documents should match the medicine and batch being offered. Missing or inconsistent information should be clarified before shipment.
4. International Supply Coordination
Cross-border pharmaceutical procurement requires coordination among the supplier, exporter, importer, logistics provider, and relevant regulatory authorities.
Buyers should discuss quotation validity, payment terms, minimum order quantities where applicable, packaging, lead times, shipping arrangements, and documentation responsibilities before confirming an order.
Clear written terms help procurement teams plan costs and coordinate deliveries more effectively.
Dolphin Pharmaceuticals: Pharmaceutical Sourcing Enquiries
Dolphin Pharmaceuticals is based in Surat, Gujarat, India, and offers pharmaceutical products across multiple therapeutic categories.
For buyers searching for a crizotinib capsules 250 mg exporter from India, the company can be contacted to discuss the specific sourcing requirement.
Before proceeding, buyers should request confirmation of:
- Whether crizotinib capsules 250 mg can be sourced.
- Available brand and product presentation.
- Actual manufacturer and manufacturing site.
- Current availability and quotation.
- Pack size and minimum order requirements, if applicable.
- Applicable product and batch documentation.
- Storage and transportation requirements.
- Registration and import eligibility for the destination market.
- Estimated lead time and shipping arrangements.
A general pharmaceutical portfolio does not establish that a particular product is currently available. Product-specific details and commercial terms should be confirmed directly before an order is finalised.
How to Choose a Reliable Crizotinib Supplier and Exporter
Selecting a pharmaceutical supplier requires a structured review of the supplier, product, and proposed transaction.
Verify Supplier Credentials
Review the supplier's legal business identity, relevant licences, and role in the pharmaceutical supply chain. Establish whether the company is the manufacturer, an authorised distributor, or an exporter sourcing the medicine from another manufacturer.
Where required, verify the relevant authorisations for the manufacturer, exporter, and importing organisation.
Confirm Product Specifications
Ensure that the product matches the procurement requirement, including:
- Generic name: crizotinib.
- Strength: 250 mg per capsule.
- Dosage form: capsule.
- Manufacturer and manufacturing site.
- Brand name, where applicable.
- Packaging configuration and quantity.
Confirm that the product information and proposed packaging correspond to the exact medicine being purchased.
Review Quality and Batch Documentation
Request applicable product and batch records. Check the medicine name, strength, manufacturer, batch number, expiry information, and other relevant details for consistency.
Any discrepancy should be resolved before approving the proposed shipment.
Assess Storage and Transportation
Review the manufacturer's approved storage instructions and ensure that the shipping arrangements are suitable for the product.
Some crizotinib capsule labels specify storage below 30°C, but the exact product label should determine the applicable requirements. Buyers should also consider transit time, customs clearance, packaging integrity, and remaining shelf life upon arrival.
Compare Complete Quotations
Compare supplier quotations using identical product specifications and clearly defined commercial terms.
Consider unit price, order quantity, packaging, documentation, freight, insurance where applicable, payment conditions, and estimated delivery time.
The lowest price alone does not establish product quality, authenticity, or regulatory eligibility.
Quality Documentation for Crizotinib Procurement
Documentation requirements depend on the product, manufacturer, transaction, and destination-country regulations.
Commercial Documents
Common commercial records may include:
- Proforma invoice.
- Commercial invoice.
- Packing list.
- Purchase order and agreed sales terms.
- Applicable transport documentation.
Product and Quality Documents
Depending on the transaction, buyers may need:
- Product specifications and approved product information.
- Manufacturer and manufacturing-site details.
- Batch number and expiry information.
- Certificate of Analysis, where applicable.
- Relevant manufacturing or quality certificates.
- Product registration or approval records, where required.
Regulatory Documents
Buyers should establish whether product registration, an import permit, importer authorisation, or additional regulatory approval is required.
Institutional or public procurement programmes may have additional supplier qualification or product quality-assurance requirements.
Not every document applies to every shipment. The importer should confirm the exact requirements with the relevant authorities and supply-chain partners before dispatch.
Regulatory Compliance for Global Crizotinib Supply
Pharmaceutical export and import activities are governed by the applicable laws and procedures of the exporting and destination countries.
A medicine's availability in India does not automatically mean that it is authorised for import or sale in another market.
Before confirming an order, buyers should verify:
- Whether the specific crizotinib product is registered or otherwise authorised in the destination country.
- Whether an import permit or additional approval is required.
- Whether the importing organisation is authorised to receive and distribute the medicine.
- Which manufacturer, product, and quality documents must be submitted.
- Whether packaging and labelling meet local requirements.
- Whether additional conditions apply to the product or proposed shipment.
For institutional procurement, buyers should also check whether the programme requires the product to meet specific quality-assurance standards or appear on an approved supplier list.
Regulatory verification should be completed before an order is finalised or the shipment is dispatched.
Storage, Packaging, and International Shipping
Proper storage and transportation help preserve pharmaceutical product quality throughout the supply chain.
Storage Requirements
Follow the approved storage instructions for the exact crizotinib product. Some capsule presentations specify storage below 30°C. Do not assume that all products have identical requirements.
Packaging and Labelling
Confirm the available pack size and ensure that packaging and labelling meet the destination market's requirements.
The product name, strength, batch number, expiry date, and manufacturer information should be consistent with the approved product documentation.
Shelf-Life Management
Confirm the expiry date and minimum remaining shelf life required by the importer.
Allow sufficient time for international transport, customs clearance, and local distribution when planning the shipment.
Shipment Coordination
Agree on the shipping method, expected dispatch date, transit time, packaging requirements, and documentation responsibilities before dispatch.
The exporter, importer, and logistics provider should coordinate to ensure that the shipment follows the product's documented handling requirements.
How to Request a Quotation from Dolphin Pharmaceuticals
A clear product enquiry helps the supplier evaluate the requirement and determine whether a suitable sourcing option may be available.
International buyers should provide:
- Required product: crizotinib capsules 250 mg.
- Preferred brand or manufacturer, if applicable.
- Required quantity.
- Preferred packaging configuration.
- Destination country.
- Known registration or import requirements.
- Required quality and regulatory documents.
- Preferred delivery schedule.
Buyers should request written confirmation of the product specifications, actual manufacturer, availability, commercial terms, supporting documentation, and export eligibility.
The quotation should clearly identify the product being offered so the buyer can compare it against the original procurement specification.
Frequently Asked Questions
1. What are crizotinib capsules 250 mg used for?
Crizotinib is a targeted anticancer medicine used for certain cancers with specific molecular characteristics. Approved indications vary by product and jurisdiction, and treatment must be supervised by qualified healthcare professionals.
2. What is the strength and dosage form?
The requested product contains 250 mg of crizotinib per oral capsule. Buyers should verify the exact product presentation and packaging.
3. Can crizotinib capsules 250 mg be exported from India?
International supply may be possible when the product, exporter, importer, and transaction meet the applicable requirements. Availability and export eligibility must be confirmed for the exact product and destination.
4. Does Dolphin Pharmaceuticals currently stock crizotinib 250 mg?
Current stock and sourcing availability must be confirmed directly with Dolphin Pharmaceuticals. Buyers should provide the required quantity, preferred manufacturer, packaging, and destination country.
5. Which documents should buyers request?
Depending on the product and destination, buyers may need product specifications, manufacturer details, batch information, a Certificate of Analysis where applicable, quality certificates, and relevant registration or import documents.
6. How should crizotinib capsules be stored?
Follow the storage conditions stated in the approved product label. Some presentations specify storage below 30°C, but the requirements for the exact product supplied take precedence.
7. Can crizotinib be exported to every international market?
No. Registration, import permits, importer authorisation, and other regulatory requirements vary by country. Buyers should verify the applicable rules before confirming an order.
Conclusion
Finding a dependable crizotinib capsules 250 mg exporter from India requires careful evaluation of product specifications, manufacturer credentials, quality documentation, regulatory compliance, and international logistics.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be contacted to discuss potential sourcing requirements for crizotinib capsules 250 mg. Buyers should confirm the exact product, manufacturer, current availability, supporting documents, commercial terms, and destination-market eligibility before finalising an order.
For pharmaceutical importers, distributors, and institutional procurement teams, a clearly defined product requirement and documented supplier review can support a more transparent and organised procurement process.
Planning a crizotinib procurement enquiry? Prepare the required quantity, preferred manufacturer, destination country, and documentation requirements so that Dolphin Pharmaceuticals can assess the request and clarify the next steps.
Disclaimer: This article is intended for pharmaceutical procurement and general informational purposes only. Crizotinib is a prescription anticancer medicine. Treatment decisions must be made by qualified healthcare professionals, and the medicine should be supplied through authorised pharmaceutical channels.
My Company Name - Dolphin Pharmaceuticals
My Website - https://www.dolphinpharma.in/